• Refine Query
  • Source
  • Publication year
  • to
  • Language
  • 24
  • 10
  • 4
  • 3
  • Tagged with
  • 4832
  • 1483
  • 1397
  • 1341
  • 1270
  • 1247
  • 356
  • 136
  • 111
  • 95
  • 91
  • 90
  • 58
  • 58
  • 58
  • About
  • The Global ETD Search service is a free service for researchers to find electronic theses and dissertations. This service is provided by the Networked Digital Library of Theses and Dissertations.
    Our metadata is collected from universities around the world. If you manage a university/consortium/country archive and want to be added, details can be found on the NDLTD website.
101

Studies on the pharmacology of some antimalarial drugs

Ojewole, J. A. O. January 1976 (has links)
Pharmacological studies of the antimalarial drugs chloroquine, primaquine, quinine, progtianil and pyrimethamine have been made. These studies have shown that the compounds possess a wide spectrum of pharmacological actions in common on many tissues and organ-systems. In most cases, their effects were biphasic, consisting of an initial stimulation followed by a more permanent inhibitory phase. All five antimalarial compounds, at low concentrations, reduced the base-line tone (tension) of all smooth muscles studied, and augmented electrically-induced contractions of the chick oesophagus, vas deferens and central ear artery preparations. Higher concentrations of the drugs dose-dependently contracted gastrointestinal smooth muscles and inhibited the spontaneous, myogenic rhythmic contractions of intestinal muscles, uterine strips and portal veins in vitro in a dose-dependent manner. In the same dose range they inhibited the electrically-evoked contractions of the chick oesophagus, vas deferens and central ear artery preparations. The drugs relaxed tracheal chain preparations contracted with acetylcholine (in the presence of physostigmine), carbachol, histamine and 5-hydroxytryptamine. In vitro, all five compounds antagonised the actions of standard spasmogens in all preparations examined. This spasmolytic effect of the drugs has been shown to be non-specific in nature. All the five compounds, in very low dosos, augmented the action of acetylcholine on frog rectus abdominis and chick biventer-cervicis muscles. High concentrations of the drugs themselves caused dose-related sustained contractions of the muscles in vitro. In similar concentrations they inhibited, or abolished, the actions of acetylcholine, carbachol, nicotine and potassium chloride. In some cases, low concentrations of the compounds, especially quinine, chloroquine and primaquine, augmented electrically-induced twitches of the chick biventer and rat hemi-diaphragm muscles in vitro, and of the soleus and tibialis anterior muscles of the cat in vivo. High doses of the compounds, themselves inhibited the twitches in a dose-related manner, and augmented the effects of neuromuscular blocking agents on the preparations. The drugs also inhibited tho tetanic as well as the intra-arterially injected acetylcholine- induced contractions of the tibialis anterior muscle in vivo. All the five compounds possessed anticholinesterase activity. In isolated cardiac muscle, all the five drugs studied increased the refractory period and caused negative inotropic and chronotropic responses. However, low concentrations of the quinoline compounds (primaquine, chloroquine and quinine) induced slight but measurable transient positive inotropic and chronotropic affects in the heart. Intravenous injections of each of the five compounds into anaesthetized cats produced similar cardiovascular changes. Those changes consisted of dose-dependent reductions in systemic and pulmonary arterial pressures, left ventricular pressure, left ventricular dP/dt max; and heart rate. Other changes consisted of dose-related increases in right atrial and left ventricular, end-diastolic pressures, P-R interval and QRS complex duration. All the compounds inhibited or abolished the pressor effects of intravenous noradrenaline on the cardiovascular system.
102

The role of γ-aminobutyric acid in central synaptic transmission

Srinivasan, Vasanta January 1971 (has links)
No description available.
103

New approaches to improve cyclosporin A monitoring

David, Oliver Jean Claude January 2001 (has links)
No description available.
104

The regulation of tumour necrosis factor-alpha and interleukin-10 by interleukin-13 in monocytic cells

Cavendish, Victoria Jane January 2002 (has links)
No description available.
105

Electrophysiological and cardiovascular actions of oxytocin and neurotensin in rat dorsal vagal complex

Tian, Song January 1997 (has links)
No description available.
106

Calcium stores and human vascular smooth muscle cell proliferation

Rowe, Daniel Thomas David January 2001 (has links)
No description available.
107

The role of folate metabolism in the mechanism of action of phenytoin

Ball, P. E. January 1981 (has links)
No description available.
108

Enzymology and induction of hepatic cytochrome P450s in the guinea pig

Ing, Rachael Helen January 2001 (has links)
No description available.
109

Cellular effects of cerebral ischaemia in vitro : cerebroprotective actions of GABAmimetic agents

Nelson, Rachael Mary January 2002 (has links)
No description available.
110

Studies of the effects of sulphonylureas on insulin secretion

Papadakis, Emmanuel January 1992 (has links)
No description available.

Page generated in 0.0134 seconds